Published in J Neuroimaging on April 01, 2011
Axonal loss of retinal neurons in multiple sclerosis associated with optic radiation lesions. Neurology (2014) 1.66
Automated vs. conventional tractography in multiple sclerosis: variability and correlation with disability. Neuroimage (2009) 1.27
Diffusion tensor imaging of the optic nerve in multiple sclerosis: association with retinal damage and visual disability. AJNR Am J Neuroradiol (2011) 0.93
Optic radiation damage in multiple sclerosis is associated with visual dysfunction and retinal thinning--an ultrahigh-field MR pilot study. Eur Radiol (2014) 0.90
Neuroimaging in multiple sclerosis: neurotherapeutic implications. Neurotherapeutics (2011) 0.85
Amiloride Clinical Trial In Optic Neuritis (ACTION) protocol: a randomised, double blind, placebo controlled trial. BMJ Open (2015) 0.85
Relationship between optical coherence tomography and electrophysiology of the visual pathway in non-optic neuritis eyes of multiple sclerosis patients. PLoS One (2014) 0.85
Imaging the visual pathway in neuromyelitis optica. Mult Scler Int (2011) 0.83
White matter changes linked to visual recovery after nerve decompression. Sci Transl Med (2014) 0.80
Optical Coherence Tomography and Magnetic Resonance Imaging in Multiple Sclerosis and Neuromyelitis Optica Spectrum Disorder. Int J Mol Sci (2016) 0.75
Exploring the Association between Retinal Nerve Fiber Layer Thickness and Initial Magnetic Resonance Imaging Findings in Patients with Acute Optic Neuritis. Mult Scler Int (2011) 0.75
Trans-synaptic degeneration in the optic pathway. A study in clinically isolated syndrome and early relapsing-remitting multiple sclerosis with or without optic neuritis. PLoS One (2017) 0.75
Fast robust automated brain extraction. Hum Brain Mapp (2002) 41.79
Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology (1983) 40.64
Three-dimensional tracking of axonal projections in the brain by magnetic resonance imaging. Ann Neurol (1999) 17.45
Axonal transection in the lesions of multiple sclerosis. N Engl J Med (1998) 12.21
DtiStudio: resource program for diffusion tensor computation and fiber bundle tracking. Comput Methods Programs Biomed (2006) 7.65
Automated image registration: II. Intersubject validation of linear and nonlinear models. J Comput Assist Tomogr (1998) 6.75
Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology (2006) 4.72
Retinal nerve fiber layer is associated with brain atrophy in multiple sclerosis. Neurology (2007) 4.72
Development of a multiple sclerosis functional composite as a clinical trial outcome measure. Brain (1999) 4.41
About "axial" and "radial" diffusivities. Magn Reson Med (2009) 4.13
Axonal damage in acute multiple sclerosis lesions. Brain (1997) 3.88
Quantifying axonal loss after optic neuritis with optical coherence tomography. Ann Neurol (2006) 3.73
Analysis of partial volume effects in diffusion-tensor MRI. Magn Reson Med (2001) 3.66
Retinal nerve fiber layer axonal loss and visual dysfunction in optic neuritis. Ann Neurol (2005) 3.45
Effects of diffusion weighting schemes on the reproducibility of DTI-derived fractional anisotropy, mean diffusivity, and principal eigenvector measurements at 1.5T. Neuroimage (2007) 2.92
The clinico-radiological paradox in multiple sclerosis revisited. Curr Opin Neurol (2002) 2.85
Clinical practice. Optic neuritis. N Engl J Med (2006) 2.61
Optical coherence tomography and disease subtype in multiple sclerosis. Neurology (2007) 2.56
Disability in optic neuritis correlates with diffusion tensor-derived directional diffusivities. Neurology (2008) 2.33
An investigation of the retinal nerve fibre layer in progressive multiple sclerosis using optical coherence tomography. Brain (2007) 2.18
Regional DTI differences in multiple sclerosis patients. Neuroimage (2008) 2.03
Relation of vision to global and regional brain MRI in multiple sclerosis. Neurology (2007) 1.89
Diffusion tensor magnetic resonance imaging of Wallerian degeneration in rat spinal cord after dorsal root axotomy. J Neurosci (2009) 1.79
Axonal injury detected by in vivo diffusion tensor imaging correlates with neurological disability in a mouse model of multiple sclerosis. NMR Biomed (2008) 1.78
Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain (1998) 1.71
Retinal pathologic changes in multiple sclerosis. Retina (1994) 1.71
Multiparametric magnetic resonance imaging analysis of the corticospinal tract in multiple sclerosis. Neuroimage (2007) 1.62
Quantitative characterization of the corticospinal tract at 3T. AJNR Am J Neuroradiol (2006) 1.62
New low-contrast vision charts: reliability and test characteristics in patients with multiple sclerosis. Mult Scler (2000) 1.60
Size-selective neuronal changes in the anterior optic pathways suggest a differential susceptibility to injury in multiple sclerosis. Brain (2001) 1.60
Contrast sensitivity, acuity, and the perception of 'real-world' targets. Br J Ophthalmol (1987) 1.50
Contrast letter acuity as a visual component for the Multiple Sclerosis Functional Composite. Neurology (2003) 1.46
Natalizumab reduces visual loss in patients with relapsing multiple sclerosis. Neurology (2007) 1.45
Damage to the optic radiation in multiple sclerosis is associated with retinal injury and visual disability. Arch Neurol (2009) 1.43
Low-contrast letter acuity testing captures visual dysfunction in patients with multiple sclerosis. Neurology (2005) 1.43
Optic nerve atrophy and retinal nerve fibre layer thinning following optic neuritis: evidence that axonal loss is a substrate of MRI-detected atrophy. Neuroimage (2006) 1.41
Retinal nerve fiber layer thickness is associated with brain MRI outcomes in multiple sclerosis. J Neurol Sci (2007) 1.39
Retinal nerve fiber layer atrophy is associated with physical and cognitive disability in multiple sclerosis. Mult Scler (2008) 1.28
Axonal loss in the retinal nerve fiber layer in patients with multiple sclerosis. Mult Scler (2008) 1.27
The ocular manifestations of multiple sclerosis. 1. Abnormalities of the afferent visual system. J Neurol Neurosurg Psychiatry (1992) 1.26
Optic nerve diffusion changes and atrophy jointly predict visual dysfunction after optic neuritis. Neuroimage (2009) 1.22
Optic nerve diffusion measurement from diffusion-weighted imaging in optic neuritis. AJNR Am J Neuroradiol (2005) 1.21
Subclinical visual involvement in multiple sclerosis: a study by MRI, VEPs, frequency-doubling perimetry, standard perimetry, and contrast sensitivity. Invest Ophthalmol Vis Sci (2005) 1.20
Nerve fiber layer of the primate retina: thickness and glial content. Vision Res (1983) 1.18
Corticospinal tract abnormalities are associated with weakness in multiple sclerosis. AJNR Am J Neuroradiol (2007) 1.17
The role of optical coherence tomography in multiple sclerosis: expert panel consensus. J Neurol Sci (2007) 1.10
Reconstruction of the human visual system based on DTI fiber tracking. J Magn Reson Imaging (2007) 1.02
Optic neuritis as onset manifestation of multiple sclerosis: a nationwide, long-term survey. Neurology (1999) 1.02
Self-reported visual dysfunction in multiple sclerosis: new data from the VFQ-25 and development of an MS-specific vision questionnaire. Am J Ophthalmol (2002) 0.95
Picturing multiple sclerosis: conventional and diffusion tensor imaging. Semin Neurol (2008) 0.95
Symptomatic retrochiasmal lesions in multiple sclerosis: clinical features, visual evoked potentials, and magnetic resonance imaging. Neurology (1992) 0.91
High-resolution anatomic, diffusion tensor, and magnetization transfer magnetic resonance imaging of the optic chiasm at 3T. J Magn Reson Imaging (2005) 0.91
Diffusion tensor MRI in multiple sclerosis. J Neuroimaging (2007) 0.91
Diffusion weighted callosal integrity reflects interhemispheric communication efficiency in multiple sclerosis. Neuropsychologia (2008) 0.85
Callosal function in MS patients with mild and severe callosal damage as reflected by diffusion tensor imaging. Brain Res (2008) 0.83
A 3-year diffusion tensor MRI study of grey matter damage progression during the earliest clinical stage of MS. J Neurol (2008) 0.81
Magnetic resonance imaging of optic tract involvement in multiple sclerosis. Am J Ophthalmol (1987) 0.79
Natalizumab plus interferon beta-1a for relapsing multiple sclerosis. N Engl J Med (2006) 6.25
Tract probability maps in stereotaxic spaces: analyses of white matter anatomy and tract-specific quantification. Neuroimage (2007) 5.23
Relation of visual function to retinal nerve fiber layer thickness in multiple sclerosis. Ophthalmology (2006) 4.72
Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial. Lancet (2011) 3.76
Primary retinal pathology in multiple sclerosis as detected by optical coherence tomography. Brain (2011) 3.48
Photoreceptor layer thinning in idiopathic Parkinson's disease. Mov Disord (2014) 3.36
Rituximab in patients with primary progressive multiple sclerosis: results of a randomized double-blind placebo-controlled multicenter trial. Ann Neurol (2009) 3.35
Multi-parametric neuroimaging reproducibility: a 3-T resource study. Neuroimage (2010) 3.32
Kv1.3 channels are a therapeutic target for T cell-mediated autoimmune diseases. Proc Natl Acad Sci U S A (2006) 3.13
A topology-preserving approach to the segmentation of brain images with multiple sclerosis lesions. Neuroimage (2009) 3.07
The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS. J Clin Invest (2003) 3.02
Optical coherence tomography in multiple sclerosis: a systematic review and meta-analysis. Lancet Neurol (2010) 2.99
Longitudinal study of vision and retinal nerve fiber layer thickness in multiple sclerosis. Ann Neurol (2010) 2.96
Effects of diffusion weighting schemes on the reproducibility of DTI-derived fractional anisotropy, mean diffusivity, and principal eigenvector measurements at 1.5T. Neuroimage (2007) 2.92
Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol (2012) 2.79
miR-34 miRNAs provide a barrier for somatic cell reprogramming. Nat Cell Biol (2011) 2.79
Quantitative description of the asymmetry in magnetization transfer effects around the water resonance in the human brain. Magn Reson Med (2007) 2.76
Varicella-zoster virus encephalitis and vasculopathy in a patient treated with fingolimod. Neurology (2012) 2.54
Ganglion cell loss in relation to visual disability in multiple sclerosis. Ophthalmology (2012) 2.48
Effects of signal-to-noise ratio on the accuracy and reproducibility of diffusion tensor imaging-derived fractional anisotropy, mean diffusivity, and principal eigenvector measurements at 1.5 T. J Magn Reson Imaging (2007) 2.44
Imaging outcomes for neuroprotection and repair in multiple sclerosis trials. Nat Rev Neurol (2009) 2.43
In vivo identification of morphologic retinal abnormalities in neuromyelitis optica. Neurology (2013) 2.43
Evolution of the blood-brain barrier in newly forming multiple sclerosis lesions. Ann Neurol (2011) 2.43
Relationships between retinal axonal and neuronal measures and global central nervous system pathology in multiple sclerosis. JAMA Neurol (2013) 2.22
Optical coherence tomography segmentation reveals ganglion cell layer pathology after optic neuritis. Brain (2011) 2.21
Optical coherence tomography: a window into the mechanisms of multiple sclerosis. Nat Clin Pract Neurol (2008) 2.20
Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases. Mol Pharmacol (2005) 2.08
Active MS is associated with accelerated retinal ganglion cell/inner plexiform layer thinning. Neurology (2013) 2.06
Anti-alpha4 integrin therapy for multiple sclerosis: mechanisms and rationale. Neurology (2005) 2.06
High resolution diffusion tensor imaging of axonal damage in focal inflammatory and demyelinating lesions in rat spinal cord. Brain (2007) 2.03
Visual dysfunction in multiple sclerosis correlates better with optical coherence tomography derived estimates of macular ganglion cell layer thickness than peripapillary retinal nerve fiber layer thickness. Mult Scler (2011) 2.02
Interferon beta use and disability prevention in relapsing-remitting multiple sclerosis. JAMA Neurol (2013) 2.00
Abnormal B-cell cytokine responses a trigger of T-cell-mediated disease in MS? Ann Neurol (2010) 1.97
Health-related quality of life in multiple sclerosis: effects of natalizumab. Ann Neurol (2007) 1.88
Macular volume determined by optical coherence tomography as a measure of neuronal loss in multiple sclerosis. Arch Neurol (2009) 1.85
Diffusion tensor magnetic resonance imaging of Wallerian degeneration in rat spinal cord after dorsal root axotomy. J Neurosci (2009) 1.79
Activated T-cells inhibit neurogenesis by releasing granzyme B: rescue by Kv1.3 blockers. J Neurosci (2010) 1.69
The voltage-gated potassium channel Kv1.3 is highly expressed on inflammatory infiltrates in multiple sclerosis brain. Proc Natl Acad Sci U S A (2005) 1.69
Retinal layer segmentation of macular OCT images using boundary classification. Biomed Opt Express (2013) 1.67
Multiparametric magnetic resonance imaging analysis of the corticospinal tract in multiple sclerosis. Neuroimage (2007) 1.62
Optical coherence tomography (OCT): imaging the visual pathway as a model for neurodegeneration. Neurotherapeutics (2011) 1.57
Multifocal visual evoked potentials are influenced by variable contrast stimulation in MS. Neurology (2012) 1.51
Optic nerve head component responses of the multifocal electroretinogram in MS. Neurology (2013) 1.46
The efficacy of natalizumab in patients with relapsing multiple sclerosis: subgroup analyses of AFFIRM and SENTINEL. J Neurol (2009) 1.46
Damage to the optic radiation in multiple sclerosis is associated with retinal injury and visual disability. Arch Neurol (2009) 1.43
Multiple repeat caesarean section: is it safe? Eur J Obstet Gynecol Reprod Biol (2005) 1.42
Induction of IL-17 and nonclassical T-cell activation by HIV-Tat protein. Proc Natl Acad Sci U S A (2013) 1.41
Bystander modulation of chemokine receptor expression on peripheral blood T lymphocytes mediated by glatiramer therapy. Arch Neurol (2005) 1.40
Sensorimotor dysfunction in multiple sclerosis and column-specific magnetization transfer-imaging abnormalities in the spinal cord. Brain (2009) 1.38
In vivo assessment of retinal neuronal layers in multiple sclerosis with manual and automated optical coherence tomography segmentation techniques. J Neurol (2012) 1.36
Amide proton transfer imaging of the breast at 3 T: establishing reproducibility and possible feasibility assessing chemotherapy response. Magn Reson Med (2012) 1.35
Pulsed magnetization transfer imaging with body coil transmission at 3 Tesla: feasibility and application. Magn Reson Med (2006) 1.34
Micro-compartment specific T2* relaxation in the brain. Neuroimage (2013) 1.34
Neural coding of spatial phase in V1 of the macaque monkey. J Neurophysiol (2003) 1.32
Kv1.3-blocking 5-phenylalkoxypsoralens: a new class of immunomodulators. Mol Pharmacol (2004) 1.31
Reproducibility of high-resolution optical coherence tomography in multiple sclerosis. Mult Scler (2010) 1.29
Axonal protective effects of the myelin-associated glycoprotein. J Neurosci (2009) 1.29
Characterization of the functional properties of the voltage-gated potassium channel Kv1.3 in human CD4+ T lymphocytes. J Immunol (2007) 1.27
Automated vs. conventional tractography in multiple sclerosis: variability and correlation with disability. Neuroimage (2009) 1.27
Revisiting brain atrophy and its relationship to disability in multiple sclerosis. PLoS One (2012) 1.26
Penalized functional regression analysis of white-matter tract profiles in multiple sclerosis. Neuroimage (2011) 1.26
Development of chemical exchange saturation transfer at 7 T. Magn Reson Med (2011) 1.26
PEGylation of interferon-β-1a: a promising strategy in multiple sclerosis. CNS Drugs (2012) 1.25
A defect of sphingolipid metabolism modifies the properties of normal appearing white matter in multiple sclerosis. Brain (2008) 1.25
Reproducibility of optical coherence tomography in multiple sclerosis. Arch Neurol (2008) 1.25
Assessment of ischemic penumbra in patients with hyperacute stroke using amide proton transfer (APT) chemical exchange saturation transfer (CEST) MRI. NMR Biomed (2013) 1.23
Nonexponential T₂ decay in white matter. Magn Reson Med (2011) 1.21
Retinal imaging by laser polarimetry and optical coherence tomography evidence of axonal degeneration in multiple sclerosis. Arch Neurol (2008) 1.20
Granzyme B mediates neurotoxicity through a G-protein-coupled receptor. FASEB J (2006) 1.19
NMDA receptor signaling in oligodendrocyte progenitors is not required for oligodendrogenesis and myelination. J Neurosci (2011) 1.18
Seven-tesla phase imaging of acute multiple sclerosis lesions: a new window into the inflammatory process. Ann Neurol (2013) 1.18
One eye or two: a comparison of binocular and monocular low-contrast acuity testing in multiple sclerosis. Am J Ophthalmol (2011) 1.17
Modeling functional data with spatially heterogeneous shape characteristics. Biometrics (2011) 1.16
Inhibition of FLT3 signaling targets DCs to ameliorate autoimmune disease. Proc Natl Acad Sci U S A (2005) 1.14
Interleukin-17 in transverse myelitis and multiple sclerosis. J Neuroimmunol (2008) 1.14
Quantitative measures detect sensory and motor impairments in multiple sclerosis. J Neurol Sci (2011) 1.14
Reconstruction of the human cerebral cortex robust to white matter lesions: method and validation. Hum Brain Mapp (2013) 1.14
Novel mechanisms of immune modulation of natalizumab in multiple sclerosis patients. J Neuroimmunol (2011) 1.13
Population-wide principal component-based quantification of blood-brain-barrier dynamics in multiple sclerosis. Neuroimage (2011) 1.13
Agar-gelatin for embedding tissues prior to paraffin processing. Biotechniques (2007) 1.11